Alpha Linolenic Acid
Showing 26 - 50 of >10,000
Weight Trajectory Trial in San Francisco (gamma-linolenic acid, )
Active, not recruiting
- Weight Trajectory
- gamma-linolenic acid
- placebo
-
San Francisco, CaliforniaVirta Health
Mar 29, 2021
Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)
Recruiting
- Depressive Disorder, Major
- +2 more
- Ketamine
- +2 more
-
New Haven, ConnecticutYale University
Aug 8, 2022
No-Reflow Phenomenon Trial (Alpha Lipoic Acid plus the standard care for post-PCI MI, The standard care for post-PCI MI)
Not yet recruiting
- No-Reflow Phenomenon
- Alpha Lipoic Acid plus the standard care for post-PCI MI
- The standard care for post-PCI MI
- (no location specified)
Apr 29, 2022
Diabetic Neuropathies, Diabetes, Dietary Supplement Trial in Thessaloníki (Epineuron, Placebo group)
Completed
- Diabetic Neuropathies
- +2 more
- Epineuron
- Placebo group
-
Thessaloníki, Thessaloniki, GreeceUniversity General Hospital AHEPA
Aug 8, 2023
Pancreas Adenocarcinoma Trial in Detroit, Milwaukee (CPI-613® (Dose level -1.0 250 mg/m^2), CPI-613® (Dose level 1.0 500
Recruiting
- Pancreas Adenocarcinoma
- CPI-613® (Dose level -1.0 250 mg/m^2)
- +6 more
-
Detroit, Michigan
- +1 more
Nov 9, 2022
Diabetes, Type 2 Trial in Nashville (L-Lysine, Normal Saline)
Enrolling by invitation
- Diabetes Mellitus, Type 2
- L-Lysine
- Normal Saline
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 11, 2022
Pompe Disease Infantile-Onset Trial in China (GC301)
Not yet recruiting
- Pompe Disease Infantile-Onset
- GC301
-
Beijing, China
- +4 more
Apr 2, 2023
Antioxidative Stress, End Stage Renal Disease on Dialysis Trial in Cairo (Alpha lipoic acid, Selenium)
Completed
- Antioxidative Stress
- End Stage Renal Disease on Dialysis
- Alpha lipoic acid
- Selenium
-
Cairo, EgyptAin Shams University
Mar 1, 2022
Multiple Sclerosis, Relapsing-Remitting Trial in Iowa City (BodyBio Balance Oil, Kirunal Fish Oil, BodyBio PC)
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
- BodyBio Balance Oil
- +5 more
-
Iowa City, IowaUniveristy of Iowa
Jun 30, 2022
Breast Cancer, Chemotherapeutic Toxicity Trial in Tanta (Alpha-lipoic acid Plus Chemotherapy (doxorubicin (also known as
Completed
- Breast Cancer
- Chemotherapeutic Toxicity
- Alpha-lipoic acid Plus Chemotherapy (doxorubicin (also known as Adriamycin) plus cyclophosphamide followed by taxol)
- Placebo Plus Chemotherapy (doxorubicin (also known as Adriamycin) plus cyclophosphamide followed by taxol)
-
Tanta, Gharbia, EgyptTanta Oncology Center
Oct 4, 2021
Healthy Trial (200mg GCE +200mg ALA, 200mg GCE +400mg ALA, 200mg GCE + 200mg DHB)
Not yet recruiting
- Healthy
- 200mg GCE +200mg ALA
- +3 more
- (no location specified)
Nov 13, 2023
Burning Mouth Syndrome Trial (drug, other, dietary supplement, radiation)
Not yet recruiting
- Burning Mouth Syndrome
- topical placebo tablet
- +5 more
- (no location specified)
Sep 10, 2023
Infantile-onset Pompe Disease Trial in Beijing (Genetic: GC301)
Recruiting
- Infantile-onset Pompe Disease
- Genetic: GC301
-
Beijing, Beijing, ChinaBayi Children's Hospital, Seventh Medical Center, PLA general ho
Sep 30, 2022
Healthy Trial (alpha-linolenic acid-rich supplement)
Completed
- Healthy
- alpha-linolenic acid-rich supplement
- (no location specified)
Feb 11, 2019
Child Obesity Trial in Verona (wNUTS, low-caloric diet plus nuts, w/oNUTS, low-caloric diet without nuts)
Terminated
- Child Obesity
- wNUTS, low-caloric diet plus nuts
- w/oNUTS, low-caloric diet without nuts
-
Verona, VR, ItalyAOUI Verona
May 18, 2022
Adolescent Migraine Trial in Bhubaneswar (Flunarizine 5mg, Alpha lipoic acid 300mg)
Recruiting
- Adolescent Migraine
- Flunarizine 5mg
- Alpha lipoic acid 300mg
-
Bhubaneswar, Odisha, IndiaAIIMS
Oct 26, 2021
Mucositis (MeSH Unique ID: D052016), Stomatitis (MeSH Unique ID: D013280) Trial (1. alpha acid lipoic - tables, 2. ozonated oil
Not yet recruiting
- Mucositis (MeSH Unique ID: D052016)
- Stomatitis (MeSH Unique ID: D013280)
- 1. alpha acid lipoic - tables
- +3 more
- (no location specified)
Jan 26, 2022
Asthma Trial in Pittsburgh (Conjugated Linolenic Acid, Sodium Nitrite, Sodium Nitrate)
Completed
- Asthma
- Conjugated Linolenic Acid
- +2 more
-
Pittsburgh, PennsylvaniaThe University of Pittsburgh Asthma Institute at UPMC
Apr 5, 2021
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Tumor Lysis Syndrome Trial in Houston (Pegloticase, Rasburicase)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Healthy Trial in Nashville (Lysine, Controlled Diet)
Enrolling by invitation
- Healthy
- Lysine
- Controlled Diet
-
Nashville, TennesseeVanderbilt University Medical Center
Sep 27, 2021
Cystinuria Trial in San Francisco (Alpha lipoic acid, Placebo)
Active, not recruiting
- Cystinuria
- Alpha lipoic acid
- Placebo
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 31, 2021
Multiple Sclerosis Trial in Canada, United States (Lipoic acid, Placebo)
Active, not recruiting
- Multiple Sclerosis
- Lipoic acid
- Placebo
-
Birmingham, Alabama
- +10 more
Jan 31, 2023
Radiation-Induced Mucositis Trial in Cairo (drug, other, radiation)
Not yet recruiting
- Radiation-Induced Mucositis
- Alpha Lipoic Acid 600 MG Oral Tablets
- +2 more
-
Cairo, EgyptAin Shams University
Aug 20, 2021
COVID-19 Trial in Orange (NAC (N-acetyl cysteine) , Alpha lipoic acid (ALA), liposomal glutathione (GSH))
Not yet recruiting
- COVID-19
- NAC (N-acetyl cysteine) , Alpha lipoic acid (ALA), liposomal glutathione (GSH)
-
Orange, CaliforniaUniversity of California Irvine Medical Center
May 10, 2022